Biofrontera Inc.
BFRI
$0.86
$0.0121.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 50.09% | 11.78% | 51.45% | 40.40% | -68.80% |
| Total Depreciation and Amortization | -3.98% | 7.99% | -20.94% | -18.57% | -15.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -832.94% | 108.93% | -288.50% | -398.86% | 106.31% |
| Change in Net Operating Assets | 218.04% | 241.37% | 125.86% | 92.70% | -180.62% |
| Cash from Operations | 54.91% | 58.75% | 25.44% | 33.01% | -38.00% |
| Capital Expenditure | 191.67% | -100.00% | 100.00% | 100.00% | -2.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.34% | -98.88% | 104.66% | 109.17% | 113.31% |
| Cash from Investing | -100.95% | -100.48% | 104.61% | 109.14% | 112.26% |
| Total Debt Issued | -83.96% | -83.96% | -13.61% | 242.95% | -- |
| Total Debt Repaid | 89.43% | 79.78% | -16.55% | -352.05% | -- |
| Issuance of Common Stock | -38.88% | 235.03% | -- | 323.48% | -13.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -36.41% | 76.38% | 931.17% | 220.57% | 1.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.03% | 128.76% | 97.73% | 99.73% | -8.61% |